Download PDF
Journal of Pediatric Epilepsy 2015; 04(02): 072-079
DOI: 10.1055/s-0035-1555600
Original Article
Georg Thieme Verlag KG Stuttgart · New York

Medication Nonadherence in Children with Epilepsy Attending Outpatient Clinics in Under-Resourced Community

Muhammad Akbar Malik
1   Division of Neurology, Department of Pediatrics, The Brain Associates Institute, Model Town, Lahore, Pakistan
,
Nadeem Shabbir
2   Division of Neurology, Department of Pediatrics, Nassau University and Medical Center, New York, United States
,
Muhammad Saeed
3   Division of Neurology, Department of Pediatrics, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia
,
Hamza Malik
1   Division of Neurology, Department of Pediatrics, The Brain Associates Institute, Model Town, Lahore, Pakistan
,
Adnan Mirza
4   Division of Neonatology, Department of Pediatrics, Arryan Hospital, Riyadh, Saudi Arabia
› Author Affiliations
Further Information

Publication History

21 July 2014

23 December 2014

Publication Date:
31 July 2015 (online)

    Permissions and Reprints

Abstract

Nonadherence to epilepsy medications can interfere with treatment and may adversely affect clinical outcomes, although few studies have examined this relationship in childhood epilepsy in under-resource settings. Our aim was to determine the rate of anti-epileptic drugs (AEDs) nonadherence in families caring for a child or adolescent with epilepsy, and to describe some associated factors in under-resource settings. A cross-sectional snapshot descriptive study design was used. Interviewer-administered structured questionnaires were completed in a sample of 120 children with epilepsy on AEDs for at least 1 month prior to the registration attending outpatient visits at free pediatric neurology camps in under-resource settings. Information was obtained about adherence to antiepileptic regimens as well as factors influencing adherence to AED regimens. Drug adherence was suboptimal in 70 (58%) and satisfactory in 50 (42%) of the patients according to self or parental report. Age of the patient and caregiver did not significantly influence the drug compliance but adherence intention, and AED prescription patterns, adverse effects, availability of AEDs, seizure control, treating physician's counseling, financial constraints, and parental/caregiver's education were more significantly associated with drug nonadherence in these communities. The assessment of medication adherence in patient-oriented epilepsy treatment programs for patients with childhood epilepsy should be a routine part of the management process to promote self-management and are essential to maximize the treatment outcome.

Keywords

medications - antiepileptic drugs - children with epilepsy - adherence - under-resource settings - Bhakkar - Pakistan
 

  • References

  • 1 Kwan P, Brodie MJ. Early identification of refractory epilepsy. N Engl J Med 2000; 342 (5) 314-319
    CrossrefPubMedGoogle Scholar
  • 2 Donovan JL, Blake DR. Patient non-compliance: deviance or reasoned decision-making?. Soc Sci Med 1992; 34 (5) 507-513
    CrossrefPubMedGoogle Scholar
  • 3 Girerd X, Hanon O, Anagnostopoulos K, Ciupek C, Mourad JJ, Consoli S. Assessment of antihypertensive compliance using a self-administered questionnaire: development and use in a hypertension clinic [in French]. Presse Med 2001; 30 (21) 1044-1048
    PubMedGoogle Scholar
  • 4 Shams ME, Barakat EA. Measuring the rate of therapeutic adherence among outpatients with T2DM in Egypt. Saudi Pharm J 2010; 18 (4) 225-232
    CrossrefPubMedGoogle Scholar
  • 5 Modi AC, Guilfoyle SM. Adherence to antiepileptic drug therapy across the developmental lifespan. In: Pinikahana J, Walker C, , eds. Society, Behaviour and Epilepsy. New York, NY: Nova Science Publishers Inc; 2011: 175-205
    Google Scholar
  • 6 Mitchell WG, Scheier LM, Baker SA. Adherence to treatment in children with epilepsy: who follows “doctor's orders”?. Epilepsia 2000; 41 (12) 1616-1625
    CrossrefPubMedGoogle Scholar
  • 7 Eatock J, Baker GA. Managing patient adherence and quality of life in epilepsy. Neuropsychiatr Dis Treat 2007; 3 (1) 117-131
    CrossrefPubMedGoogle Scholar
  • 8 Cameron A, Bansal A, Dua T , et al. Mapping the availability, price, and affordability of antiepileptic drugs in 46 countries. Epilepsia 2012; 53 (6) 962-969
    CrossrefPubMedGoogle Scholar
  • 9 Modi AC, Rausch JR, Glauser TA. Patterns of nonadherence to antiepileptic drug therapy in children with newly diagnosed epilepsy. JAMA 2011; 305 (16) 1669-1676
    CrossrefPubMedGoogle Scholar
  • 10 Al-Faris EA, Abdulghani HM, Mahdi AH, Salih MA, Al-Kordi AG. Compliance with appointments and medications in a pediatric neurology clinic at a University Hospital in Riyadh, Saudi Arabia. Saudi Med J 2002; 23 (8) 969-974
    PubMedGoogle Scholar
  • 11 Nazziwa R, Mwesige AK, Obua C, Ssenkusu JM, Mworozi E. Adherence to antiepileptic drugs among children attending a tertiary health unit in a low resource setting. Pan Afr Med J 2014; 17: 44
    PubMedGoogle Scholar
  • 12 Morisky DE, Levine DM, Green LW, Shapiro S, Russell RP, Smith CR. Five-year blood pressure control and mortality following health education for hypertensive patients. Am J Public Health 1983; 73 (2) 153-162
    CrossrefPubMedGoogle Scholar
  • 13 Lisk DR, Greene SH. Drug compliance and seizure control in epileptic children. Postgrad Med J 1985; 61 (715) 401-405
    CrossrefPubMedGoogle Scholar
  • 14 Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care 1986; 24 (1) 67-74
    CrossrefPubMedGoogle Scholar
  • 15 Green LW, Simons-Morton DG. Denial, delay and disappointment: discovering and overcoming the causes of drug errors and missed appointments. In: Schmidt D, Leppik IE, , eds. Compliance in Epilepsy. Amsterdam, The Netherlands: Elsevier Science Publishers B.V.; 1988: 7-21
    Google Scholar
  • 16 McAuley JW, McFadden LS, Elliott JO, Shneker BF. An evaluation of self-management behaviors and medication adherence in patients with epilepsy. Epilepsy Behav 2008; 13 (4) 637-641
    CrossrefPubMedGoogle Scholar
  • 17 Jones RM, Butler JA, Thomas VA, Peveler RC, Prevett M. Adherence to treatment in patients with epilepsy: associations with seizure control and illness beliefs. Seizure 2006; 15 (7) 504-508
    CrossrefPubMedGoogle Scholar
  • 18 Shope JT. Compliance in children and adults: review of studies. Epilepsy Res Suppl 1988; 1: 23-47
    PubMedGoogle Scholar
  • 19 Asadi-Pooya AA. Drug compliance of children and adolescents with epilepsy. Seizure 2005; 14 (6) 393-395
    CrossrefPubMedGoogle Scholar
  • 20 Chandra RS, Dalvi SS, Karnad PD, Kshirsagar NA, Shah PU. Compliance monitoring in epileptic patients. J Assoc Physicians India 1993; 41 (7) 431-432
    PubMedGoogle Scholar
  • 21 Kyngäs H. Compliance of adolescents with chronic disease. J Clin Nurs 2000; 9 (4) 549-556
    CrossrefPubMedGoogle Scholar
  • 22 Kyngäs H. Compliance with health regimens of adolescents with epilepsy. Seizure 2000; 9 (8) 598-604
    CrossrefPubMedGoogle Scholar
  • 23 Britten N. Patients' ideas about medicines: a qualitative study in a general practice population. Br J Gen Pract 1994; 44 (387) 465-468
    PubMedGoogle Scholar
  • 24 Islahudin F, Tan SH. Medication knowledge and adherence in nephrology patients. Int J Pharm Bio Sci 2013; 3 (1) 459-466
    PubMedGoogle Scholar
  • 25 Cramer JA. A systematic review of adherence with medications for diabetes. Diabetes Care 2004; 27 (5) 1218-1224
    CrossrefPubMedGoogle Scholar
  • 26 Yeager KA, Diiorio C, Shafer PO , et al. The complexity of treatments for persons with epilepsy. Epilepsy Behav 2005; 7 (4) 679-686
    CrossrefPubMedGoogle Scholar
  • 27 Baker GA, Jacoby A, Buck D, Stalgis C, Monnet D. Quality of life of people with epilepsy: a European study. Epilepsia 1997; 38 (3) 353-362
    CrossrefPubMedGoogle Scholar
  • 28 Deckers CL, Hekster YA, Keyser A, van Lier HJ, Meinardi H, Renier WO. Monotherapy versus polytherapy for epilepsy: a multicenter double-blind randomized study. Epilepsia 2001; 42 (11) 1387-1394
    CrossrefPubMedGoogle Scholar
  • 29 Perruca E. Pharmacokinetics. In: Engel Jr. J, Pedley TA, , eds. Epilepsy: A Comprehensive Textbook. Philadelphia, PA: Lippincott-Raven; 1997: 1131-1153
    Google Scholar
  • 30 Buck D, Jacoby A, Baker GA, Chadwick DW. Factors influencing compliance with antiepileptic drug regimes. Seizure 1997; 6 (2) 87-93
    CrossrefPubMedGoogle Scholar
  • 31 Scott RA, Lhatoo SD, Sander JW. The treatment of epilepsy in developing countries: where do we go from here?. Bull World Health Organ 2001; 79 (4) 344-351
    PubMedGoogle Scholar
  • 32 Availability and distribution of antiepileptic drugs in developing countries. III and IV Commissions on Antiepileptic Drugs of the International League Against Epilepsy. Epilepsia 1985; 26 (2) 117-121
    CrossrefPubMedGoogle Scholar
  • 33 Ettinger AB, Manjunath R, Candrilli SD, Davis KL. Prevalence and cost of nonadherence to antiepileptic drugs in elderly patients with epilepsy. Epilepsy Behav 2009; 14 (2) 324-329
    CrossrefPubMedGoogle Scholar
  • 34 Feksi AT, Kaamugisha J, Sander JW, Gatiti S, Shorvon SD ; ICBERG (International Community-based Epilepsy Research Group). Comprehensive primary health care antiepileptic drug treatment programme in rural and semi-urban Kenya. Lancet 1991; 337 (8738) 406-409
    CrossrefPubMedGoogle Scholar
  • 35 Mani KS, Rangan G, Srinivas HV, Srindharan VS, Subbakrishna DK. Epilepsy control with phenobarbital or phenytoin in rural south India: the Yelandur study. Lancet 2001; 357 (9265) 1316-1320
    CrossrefPubMedGoogle Scholar
  • 36 Shetty J, Kirkpatrick M, Greene S. Adherence to anti-epileptic medication in children with epilepsy from a Scottish population cohort. Arch Dis Child 2012; 97: A135
    PubMedGoogle Scholar
  • 37 Gopinath B, Radhakrishnan K, Sarma PS, Jayachandran D, Alexander A. A questionnaire survey about doctor-patient communication, compliance and locus of control among south Indian people with epilepsy. Epilepsy Res 2000; 39 (1) 73-82
    CrossrefPubMedGoogle Scholar
  • 38 Stanaway L, Lambie DG, Johnson RH. Non-compliance with anticonvulsant therapy as a cause of seizures. N Z Med J 1985; 98 (774) 150-152
    PubMedGoogle Scholar
  • 39 Modi AC, Morita DA, Glauser TA. One-month adherence in children with new-onset epilepsy: white-coat compliance does not occur. Pediatrics 2008; 121 (4) e961-e966
    CrossrefPubMedGoogle Scholar
  • 40 Shakya G, Malla S, Shakya KN, Shrestha R. Therapeutic drug monitoring of antiepileptic drugs. JNMA J Nepal Med Assoc 2008; 47 (171) 94-97
    PubMedGoogle Scholar
  • 41 Vincze G, Barner JC, Lopez D. Factors associated with adherence to self-monitoring of blood glucose among persons with diabetes. Diabetes Educ 2004; 30 (1) 112-125
    CrossrefPubMedGoogle Scholar
  • 42 Favre J. How to recognize and classify seizures, Epilepsy Foundation of America, 2002. Available at: http://www.medline.com . Accessed July 10, 2014
    PubMedGoogle Scholar
  • 43 Wasti SP, Simkhada P, Randall J, Freeman JV, van Teijlingen E. Factors influencing adherence to antiretroviral treatment in Nepal: a mixed-methods study. PLoS ONE 2012; 7 (5) e35547
    CrossrefPubMedGoogle Scholar
  • 44 Stephenson BJ, Rowe BH, Haynes RB, Macharia WM, Leon G. The rational clinical examination. Is this patient taking the treatment as prescribed?. JAMA 1993; 269 (21) 2779-2781
    CrossrefPubMedGoogle Scholar
  • 45 Buelow JM, Smith MC. Medication management by the person with epilepsy: perception versus reality. Epilepsy Behav 2004; 5 (3) 401-406
    CrossrefPubMedGoogle Scholar